Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Nymox Pharm Corp (NYMX)

Nymox Pharm Corp (NYMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Nymox: Q3 Earnings Snapshot AP - Wed Nov 15, 2023

Nymox: Q3 Earnings Snapshot

NYMX : 0.2000 (-19.68%)
Nymox: Q2 Earnings Snapshot AP - Mon Aug 14, 2023

Nymox: Q2 Earnings Snapshot

NYMX : 0.2000 (-19.68%)
NYMOX Updates Shareholders Globe Newswire - Fri Jul 15, 2022

IRVINE, Calif., July 15, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced an update to its shareholders regarding...

NYMX : 0.2000 (-19.68%)
NYMOX Receives Deficiency Letter from NASDAQ Globe Newswire - Thu Jul 14, 2022

IRVINE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports that on July 7, 2022 the Company received a...

NYMX : 0.2000 (-19.68%)
NYMOX Receives RTF letter from FDA Globe Newswire - Mon May 23, 2022

IRVINE, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports today that it has received a Refusal to File...

NYMX : 0.2000 (-19.68%)
Nymox Announces Closing of $6.4 Million Financing Globe Newswire - Mon Apr 4, 2022

IRVINE, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it has...

NYMX : 0.2000 (-19.68%)
Nymox Announces $5 Million Registered Direct Offering Globe Newswire - Fri Mar 18, 2022

IRVINE, Calif., March 18, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced it has entered into definitive...

NYMX : 0.2000 (-19.68%)
NYMOX Announces Submission of New Drug Application (NDA) to the FDA for Fexapotide Triflutate Globe Newswire - Thu Mar 3, 2022

IRVINE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce today that it...

NYMX : 0.2000 (-19.68%)
Nymox Shareholder Update Globe Newswire - Mon Dec 13, 2021

HASBROUCK HEIGHTS, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it...

NYMX : 0.2000 (-19.68%)
NYMOX Presenting at Torrey Hills Capital Emerging Growth Conference Globe Newswire - Mon Nov 15, 2021

NYMOX Provides Current Update...

NYMX : 0.2000 (-19.68%)

Barchart Exclusives

Should You Buy This Beaten-Down AI Stock for Its 4% Dividend Yield? Barchart - Tue Apr 23, 6:30PM CDT
Sales of AI-enabled gadgets are expected to drive hardware sales over the next few years. PC maker HP looks like an AI play worth buying for its nearly 4% dividend yield and tepid valuations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot